Chondroitinase ABC promotes functional recovery after spinal cord injury
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The inability of axons to regenerate after a spinal cord injury in the adult mammalian central nervous system (CNS) can lead to permanent paralysis. At sites of CNS injury, a glial scar develops, containing extracellular matrix molecules including chondroitin sulphate proteoglycans (CSPGs). CSPGs are inhibitory to axon growth in vitro, and regenerating axons stop at CSPG-rich regions in vivo. Removing CSPG glycosaminoglycan (GAG) chains attenuates CSPG inhibitory activity. To test the functional effects of degrading chondroitin sulphate (CS)-GAG after spinal cord injury, we delivered chondroitinase ABC (ChABC) to the lesioned dorsal columns of adult rats. We show that intrathecal treatment with ChABC degraded CS-GAG at the injury site, upregulated a regeneration-associated protein in injured neurons, and promoted regeneration of both ascending sensory projections and descending corticospinal tract axons. ChABC treatment also restored post-synaptic activity below the lesion after electrical stimulation of corticospinal neurons, and promoted functional recovery of locomotor and proprioceptive behaviours. Our results demonstrate that CSPGs are important inhibitory molecules in vivo and suggest that their manipulation will be useful for treatment of human spinal injuries.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Degradation of PNNs has been shown to reactivate early life-like plasticity also in the spinal cord and fear circuitry189,190.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [189]
In the citing paper
“In rats, iPlasticity induced either by ChABC or fluoxetine improves recovery from spinal cord lesion189,201.”
From Neuronal plasticity and neurotrophic factors in drug responses (2017) · cites this paper as [189]
In the citing paper
“As chABC removes GAG side chains from CSPGs (Bradbury et al., 2002), these results suggest that the neuroprotective effects of PNNs may be attributed to the CS-side chains of CSPGs.”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
In the citing paper
“CSPG degradation via application of chABC promoted regeneration of dorsal column axons after injury.”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
In the citing paper
“but also contributed to expanded receptive fields of uninjured primary afferents (Bradbury et al., 2002; Massey et al., 2006).”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Bradbury et al., 2002
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The glial scar and central nervous system repair
Fawcett, J. W., & Asher, R. A. (1999) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00072-6 · Cited by 1,803 · cited 1×
“At sites of CNS injury, a glial scar develops, containing extracellular matrix molecules including chondroitin sulphate proteoglycans (CSPGs)”
BackgroundSelf-citationMcKeon, R., Schreiber, R., Rudge, J., & Silver, J. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-11-03398.1991 · Cited by 1,188
Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors
Bregman, B. S., Kunkel-Bagden, E., Schnell, L., Dai, H. N., Gao, D., & Schwab, M. E. (1995) · Nature · doi:10.1038/378498a0 · Cited by 716
Davies, S. J. A., Goucher, D. R., Doller, C., & Silver, J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05810.1999 · Cited by 606 · cited 1×
“, and regenerating axons stop at CSPG-rich regions in vivo”
BackgroundMoon, L. D. F., Asher, R. A., Rhodes, K. E., & Fawcett, J. W. (2001) · Nature Neuroscience · doi:10.1038/87415 · Cited by 562
Self-citationFunctional regeneration of sensory axons into the adult spinal cord
Ramer, M. S., Priestley, J. V., & McMahon, S. B. (2000) · Nature · doi:10.1038/35002084 · Cited by 517
Self-citationMckeon, R. J., Höke, A., & Silver, J. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1081 · Cited by 486
Neurocan Is Upregulated in Injured Brain and in Cytokine-Treated Astrocytes
Asher, R. A., Morgenstern, D. A., Fidler, P. S., Adcock, K. H., Oohira, A., Braistead, J. E., Levine, J. M., Margolis, R. U., Rogers, J. H., & Fawcett, J. W. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02427.2000 · Cited by 482
Self-citationMcKeon, R. J., Jurynec, M. J., & Buck, C. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-24-10778.1999 · Cited by 480
Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury
Levine, J. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-08-04716.1994 · Cited by 393
Cited by
Items 601–700 of 1,014
Soft Bioelectronics for Therapeutics
Zhang, Z., Zhu, Z., Zhou, P., Zou, Y., Yang, J., Haick, H., & Wang, Y. (2023) · ACS Nano · doi:10.1021/acsnano.3c02513 · Cited by 87
Lee, J. K., Chow, R., Xie, F., Chow, S. Y., Tolentino, K. E., & Zheng, B. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2269-10.2010 · Cited by 76
“In addition, other classes of inhibitory influences remain in Nogo/MAG/NgR1 mutants, including chondroitin sulfate proteoglycans derived from the GFAP astroglial scar (Bradbury et al., 2002; Silver and Miller, 2004).”
BackgroundNeural Stem Cells in the Adult Nervous System
Bottai, D., Fiocco, R., Gelain, F., Filippis, L. D., Galli, R., Gritti, A., & Vescovi, L. A. (2003) · Stem Cells and Development · doi:10.1089/15258160360732687 · Cited by 79
Alluin, O., Delivet-Mongrain, H., Gauthier, M., Fehlings, M. G., Rossignol, S., & Karimi‐Abdolrezaee, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111072 · Cited by 80
“Chondroitinase ABC (ChABC) facilitates the degradation of CSPGs in the injured spinal cord [12].”
BackgroundMethodNeurotrophic factors in combinatorial approaches for spinal cord regeneration
McCall, J., Weidner, N., & Blesch, A. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1388-6 · Cited by 85
“Without a cellular graft or trophic support, ChABC treatment upon acute or subchronic SCI induces moderate plasticity of surrounding tissue and some regeneration of select axonal tracts (Alilain et al. 2011; Bradbury et al. 2002), even when coupled with acute or delayed rehabilitative train-”
Inhibitors of myelination: ECM changes, CSPGs and PTPs
Harlow, D. E., & Macklin, W. B. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2013.10.017 · Cited by 78
“Multiple studies have demonstrated thebenefit of reducedCSPGaccumulation and signaling for both axonal regeneration and remyelination (Bradbury et al., 2002; Davies et al., 2004; Huang et al., 2006; KarimiAbdolrezaee et al., 2012; Siebert et al., 2011; Soleman et al., 2012; Starkey et al., 2012;…”
InfluentialSpinal cord injury and plasticity: Opportunities and challenges
Fouad, K., Krajacic, A., & Tetzlaff, W. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.04.017 · Cited by 89
Li, H., Ham, T. R., Neill, N., Farrag, M., Mohrman, A. E., Koenig, A. M., & Leipzig, N. D. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201500810 · Cited by 83
Deciphering glial scar after spinal cord injury
Zhang, Y., Yang, S., Liu, C., Han, X., Gu, X., & Zhou, S. (2021) · Burns & Trauma · doi:10.1093/burnst/tkab035 · Cited by 87
“McMahon and coworkers found that digesting the CSPGs in the scar tissue at the injury site by intrathecal injection of chondroitinase ABC (ChABC) can effectively promote the regeneration of CST nerve axons and facilitate recovery of motor function to a certain extent [66].”
Microtissue Engineered Constructs with Living Axons for Targeted Nervous System Reconstruction
Cullen, D. K., Tang‐Schomer, M. D., Struzyna, L. A., Patel, A., Johnson, V. E., Wolf, J. A., & Smith, D. H. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0534 · Cited by 78
Biochemical characterization of the chondroitinase ABC I active site
Prabhakar, V., Raman, R., Capila, I., Bosques, C. J., Pojasek, K., & Sasisekharan, R. (2005) · Biochemical Journal · doi:10.1042/bj20050532 · Cited by 88
Signaling pathways regulating neuron–glia interaction and their implications in Alzheimer's disease
Lian, H., & Zheng, H. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13424 · Cited by 77
Extrinsic and intrinsic determinants of nerve regeneration
Ferguson, T. A., & Son, Y. (2011) · Journal of Tissue Engineering · doi:10.1177/2041731411418392 · Cited by 84
“72 Loss of PTEN likely results in phosphatidylinositol (3,4,5)-trisphosphate (PIP3) accumulation, deregulation of AKT signaling, and likely increases regeneration through multiple downstream signaling effectors (for recent review see Ref.”
BackgroundWright, K. T., Masri, W. E., Osman, A., Roberts, S., Chamberlain, G., Ashton, B. A., & Johnson, W. E. B. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.013 · Cited by 77
Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors
Sami, A., Selzer, M. E., & Li, S. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00174 · Cited by 79
Sada, N., Fujita, Y., Mizuta, N., Ueno, M., Furukawa, T., & Yamashita, T. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-02897-w · Cited by 71
Harding-Forrester, S., & Feldman, D. E. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63622-5.00004-8 · Cited by 82
Restoring nervous system structure and function using tissue engineered living scaffolds
Struzyna, L. A., Harris, J. P., Katiyar, K. S., Chen, H., & Cullen, D. K. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.156943 · Cited by 80
“…the current dogma in neu-roregenerative medicine based on transplanting stem cells for neuronal replacement and axon guidance for tract replacement (Bradbury et al., 2002; Borisoff et al., 2003; Jain et al., 2004; Tsai et al., 2004; Mingorance et al., 2006; Moore et al., 2006; Tang et al., 2007;…”
Strategies to Promote Neural Repair and Regeneration After Spinal Cord Injury
Kwon, B. K., Fisher, C. G., Dvorak, M. F., & Tetzlaff, W. (2005) · Spine · doi:10.1097/01.brs.0000175186.17923.87 · Cited by 88
“The intrathecal infusion of chondroitinase ABC after a partial spinal cord lesion was reported to promote growth of corticospinal axons and result in functional recovery.(119) The application of this strategy with cell transplantation therapies in order to attenuate the glial scar establishment at the host-transplant…”
BackgroundDirected nerve outgrowth is enhanced by engineered glial substrates
Biran, R., Noble, M., & Tresco, P. A. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00253-x · Cited by 77
Role of Chondroitin Sulfate Proteoglycans in Axonal Conduction in Mammalian Spinal Cord
Hunanyan, A. S., Garcia-Alias, G., Alessi, V., Levine, J. M., Fawcett, J. W., Mendell, L. M., & Arvanian, V. L. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4659-09.2010 · Cited by 75
“Degrading CSPGs by enzymatic removal of chondroitin sulfate chains with the chondroitin sulfate glycosaminoglycandigesting bacterial enzyme chondroitinase-ABC (Ch’ase) promotes axonal regeneration and stimulates anatomical plasticity in the damaged and undamaged brain and spinal cord and encourages functional recovery…”
BackgroundSelf-citationCombination therapies in the CNS: Engineering the environment
McCreedy, D. A., & Sakiyama‐Elbert, S. E. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.02.025 · Cited by 85
“demonstrated that chABC application following SCI could promote regeneration [7].”
BackgroundA Cytocompatible Robust Hybrid Conducting Polymer Hydrogel for Use in a Magnesium Battery
Yu, C., Wang, C., Liu, X., Jia, X., Naficy, S., Shu, K., Forsyth, M., & Wallace, G. G. (2016) · Advanced Materials · doi:10.1002/adma.201601755 · Cited by 79
Diverse functions of perineuronal nets
Karetko, M., & Skangiel-Kramska, J. (2009) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2009-1766 · Cited by 76
“Injection of ChABC to the spinal cord in the vicinity of a lesion site degrades CS proteoglycans and promotes sprouting of injured dorsal column axons and causes functional recovery (Bradbury et al. 2002).”
BackgroundExtracellular Matrix in Neural Plasticity and Regeneration
Chelyshev, Y. A., Kabdesh, I. M., & Mukhamedshina, Y. O. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00986-0 · Cited by 105
Tsata, V., Möllmert, S., Schweitzer, C., Kolb, J., Möckel, C., Böhm, B., Rosso, G., Lange, C. M., Lesche, M., Hammer, J., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2020.12.009 · Cited by 82
Realizing the maximum potential of Schwann cells to promote recovery from spinal cord injury
Bunge, M. B., & Wood, P. M. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52137-8.00032-2 · Cited by 76
Regenerative medicine for the treatment of spinal cord injury: more than just promises?
Pêgo, A. P., Kubinová, Š., Čížková, D., Vanický, I., Mar, F. M., Sousa, M. M., & Syková, E. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01603.x · Cited by 87
“It is, however, important to note that despite the growing list of studies providing evidence for axonal regeneration after SCI, even when the environmental inhibitory cues are cleared and a more permissive environment is created to support axonal regeneration, the distance of axon re-growth is very modest [165, 166]…”
BackgroundMyelin-derived ephrinB3 restricts axonal regeneration and recovery after adult CNS injury
Duffy, P. J., Wang, X., Siegel, C. S., Tu, N. C.-Y., Henkemeyer, M. J., Cafferty, W. B. J., & Strittmatter, S. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113953109 · Cited by 77
Role of CSPG receptor LAR phosphatase in restricting axon regeneration after CNS injury
Xu, B., Park, D., Ohtake, Y., Li, H., Hayat, U., Liu, J., Selzer, M. E., Longo, F. M., & Li, S. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.030 · Cited by 71
“…sulfate proteoglycans (CSPGs) are highly upregulated by reactive scar tissues and strongly suppress axon extension into and beyond the lesion by forming a non-permissive perineuronal nets with other extracellular matrix molecules (Bradbury et al., 2002; Busch and Silver, 2007; Jones et al., 2003).”
BackgroundTsai, M.-C., Shen, L., Kuo, H., Cheng, H., & Chak, K. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800076-mcp200 · Cited by 76
“Bradbury, E. J., Moon, L. D., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., and McMahon, S. B. (2002) Chondroitinase ABC promotes functional recovery after spinal cord injury.”
BackgroundInfluentialIdentification of a critical sulfation in chondroitin that inhibits axonal regeneration
Pearson, C. S., Mencio, C. P., Barber, A. C., Martin, K. R., & Geller, H. M. (2018) · eLife · doi:10.7554/elife.37139 · Cited by 75
“The formation of a glial scar, including deposition of sulfated proteoglycans, is well documented in the brain and spinal cord (Bradbury et al., 2002; Bradbury and Carter, 2011; Yi et al., 2012; Burnside and Bradbury, 2014; Galtrey and Fawcett, 2007).”
BackgroundProspects for the application of Müller glia and their derivatives in retinal regenerative therapies
Eastlake, K., Lamb, W. D. B., Luis, J., Khaw, P. T., Jayaram, H., & Limb, G. A. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100970 · Cited by 82
Chondroitinase ABC promotes axonal re-growth and behavior recovery in spinal cord injury
Huang, W., Kuo, W.-C., Cherng, J., Hsu, S.-H., Chen, P.-R., Huang, S.-H., Huang, M.-C., Liu, J.-C., & Cheng, H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.136 · Cited by 75
Central Nervous System Regeneration Inhibitors and their Intracellular Substrates
Nash, M., Pribiag, H., Fournier, A. E., & Jacobson, C. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8083-y · Cited by 84
“The family of CSPGs includes more than a half dozen members, including aggrecan, brevican, neurocan, versican, NG2, and phosphacan, that have been demonstrated to be upregulated following certain types of CNS injury [9].”
BackgroundA review of published reports on neuroprotection in spinal cord injury
Onose, G., Anghelescu, A., Muresanu, D. F., Pădure, L., Haras, M., Chendreanu, C., Onose, L., Mirea, A., Ciurea, A. V., Masri, W. S. E., et al. (2009) · Spinal Cord · doi:10.1038/sc.2009.52 · Cited by 75
Chondroitinase gene therapy improves upper limb function following cervical contusion injury
James, N. D., Shea, J. R., Muir, E. M., Verhaagen, J., Schneider, B. L., & Bradbury, E. J. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.05.022 · Cited by 79
“…an open access article under shown to have beneficial effects on spinal repair following traumatic injury bynumerous different research groups and in a number of different animal species and injury models (Ramer et al., 2014; Garcia-Alias et al., 2009; Bradbury et al., 2002; Alilain et al., 2011).”
Self-citationRebuilding Brain Circuitry with Living Micro-Tissue Engineered Neural Networks
Struzyna, L. A., Wolf, J. A., Mietus, C. J., Adewole, D. O., Chen, H.-C. I., Smith, D. H., & Cullen, D. K. (2015) · Tissue Engineering Part A · doi:10.1089/ten.tea.2014.0557 · Cited by 76
Pan, D., Li, Y., Yang, F., Lv, Z., Zhu, S., Shao, Y., Huang, Y., Ning, G., & Feng, S. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02215-x · Cited by 80
Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells
Garbossa, D., Boido, M., Fontanella, M. M., Fronda, C., Ducati, A., & Vercelli, A. (2012) · Neurosurgical Review · doi:10.1007/s10143-012-0385-2 · Cited by 79
“In vitro experiments have demonstrated that proteoglycans associated with reactive astrocytes can be modified to increase axonal growth by removing or preventing the production of sugar epitopes on the proteoglycan molecules [21,64,132,133,191].”
BackgroundJarocha, D. J., Milczarek, O., Wędrychowicz, A., Kwiatkowski, S., & Majka, M. (2015) · Cell Transplantation · doi:10.3727/096368915x687796 · Cited by 74
Xiang, Y., Dong, H., Wan, Y., Li, J., Yee, A., Yang, B. B., & Lu, W.-Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512980200 · Cited by 80
Reorganization of Intact Descending Motor Circuits to Replace Lost Connections After Injury
Fink, K. L., & Cafferty, W. B. J. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0422-x · Cited by 86
“ChABC treatment leads to the degradation of inhibitory glycosaminoglycan side chains from chondroitin sulfate core proteins [38], thus creating a more permissive environment for axon growth after SCI in adult animals [60, 82, 83].”
Wilems, T. S., Pardieck, J., Iyer, N. R., & Sakiyama‐Elbert, S. E. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.09.018 · Cited by 74
Heterogeneous astrocytes: Active players in CNS
Hu, X., Yuan, Y., Wang, D., & Su, Z. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.03.017 · Cited by 80
“Using the chondroitinase ABC (ChABC) to degrade CSPGs in lesion site significantly enhances the regeneration of severed axons in the spinal descending pathways (Bradbury et al. 2002).”
Inosine promotes recovery of skilled motor function in a model of focal brain injury
Smith, J. M., Lunga, P., Story, D., Harris, N., Le Belle, J., James, M. F., Pickard, J. D., & Fawcett, J. W. (2006) · Brain · doi:10.1093/brain/awl393 · Cited by 72
“For Permissions, please email: journals.permissions@oxfordjournals.org by guest on M ay 3, 2016 http://brain.oxfordjournals.org/ D ow nloaded from et al., 2001; Bradbury et al., 2002; Bareyre et al., 2004; Papadopoulos et al., 2006; Dancause et al., 2005; Vavrek et al., 2006).”
BackgroundSelf-citationTom, V. J., & Houlé, J. D. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.01.021 · Cited by 79
“Moreover, digestion of the GAG chains from CSPGs with ChABC (reviewed byCrespo et al., 2007) enhances regeneration and sprouting following injury (Bradbury et al., 2002; Caggiano et al., 2005; Ikegami et al., 2005; Barritt et al., 2006), further demonstrating the importance of this family of…”
InfluentialNew roles for old proteins in adult CNS axonal regeneration
Spencer, T. K., Domeniconi, M., Cao, Z., & Filbin, M. T. (2003) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(03)00012-6 · Cited by 76
Ito, Z., Sakamoto, K., Imagama, S., Matsuyama, Y., Zhang, H., Hirano, K., Ando, K., Yamashita, T., Ishiguro, N., & Kadomatsu, K. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2570-09.2010 · Cited by 73
“Chondroitinase ABC treatment has been shown to enhance functional recovery after spinal cord injury in a rat model (Bradbury et al., 2002).”
BackgroundAdaptive changes in the injured spinal cord and their role in promoting functional recovery
Fouad, K., & Tse, A. (2008) · Neurological Research · doi:10.1179/016164107x251781 · Cited by 71
Zhang, X., Zeng, Y., Zhang, W., Jun-mei, W., Wu, J., & Li, J. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2007.0334 · Cited by 78
“Scars in injured spinal cord often contain axonal growth inhibitory molecules such as chondroitin sulfate proteoglycans (CSPGs) (Bradbury et al., 2002; Huang et al., 2006; Jones et al., 2003).”
Extrinsic and intrinsic factors controlling axonal regeneration after spinal cord injury
Afshari, F. T., Kappagantula, S., & Fawcett, J. W. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001288 · Cited by 79
Self-citationMechanisms for modulation of neural plasticity and axon regeneration by chondroitin sulphate
Miyata, S., & Kitagawa, H. (2015) · Journal of Biochemistry · doi:10.1093/jb/mvu067 · Cited by 71
“Digestion of CSPGs with a bacterial enzyme called chondroitinase ABC, which degrades CS chains, enhances synaptic plasticity in the adult brain and improves axon regeneration after spinal cord injury, offering a novel therapeutic strategy for CNS diseases and injuries (12, 13).”
BackgroundAn Injectable, Calcium Responsive Composite Hydrogel for the Treatment of Acute Spinal Cord Injury
McKay, C. A., Pomrenke, R. D., McLane, J. S., Schaub, N. J., DeSimone, E. K., Ligon, L. A., & Gilbert, R. J. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am4027423 · Cited by 70
Shinozaki, M., Iwanami, A., Fujiyoshi, K., Tashiro, S., Kitamura, K., Shibata, S., Fujita, H., Nakamura, M., & Okano, H. (2016) · Neuroscience Research · doi:10.1016/j.neures.2016.07.005 · Cited by 70
Hulme, C. H., Brown, S. J., Fuller, H. R., Riddell, J. S., Osman, A., Chowdhury, J., Kumar, N., Johnson, W. E. B., & Wright, K. T. (2016) · Spinal Cord · doi:10.1038/sc.2016.174 · Cited by 77
Hu, H. Z., Granger, N. P., Pai, S. B., Bellamkonda, R. V., & Jeffery, N. D. (2018) · Brain · doi:10.1093/brain/awy007 · Cited by 73
Lemons, M. L., Sandy, J. D., Anderson, D. K., & Howland, D. R. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00383-2 · Cited by 79
The rocky road to translation in spinal cord repair
Filli, L., & Schwab, M. E. (2012) · Annals of Neurology · doi:10.1002/ana.23630 · Cited by 76
Training Neural Stem Cells on Functional Collagen Scaffolds for Severe Spinal Cord Injury Repair
Li, X., Liu, S., Zhao, Y., Li, J., Ding, W., Han, S., Chen, B., Xiao, Z., & Dai, J. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201601521 · Cited by 75
Tools for mammalian glycoscience research
Griffin, M. E., & Hsieh‐Wilson, L. C. (2022) · Cell · doi:10.1016/j.cell.2022.06.016 · Cited by 75
Sensory axon regeneration: rebuilding functional connections in the spinal cord
Smith, G. M., Falone, A. E., & Frank, E. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.10.006 · Cited by 72
“Treatment with ChABC has been particularly successful in promoting sensory axon regeneration, although in most cases it must be combined with another treatment to promote growth [42, 43].”
Jain, A., McKeon, R. J., Brady-Kalnay, S. M., & Bellamkonda, R. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016135 · Cited by 71
“Some studies have used chABC to digest the CSPGs in the inhibitory environment [28,29,30,31].”
BackgroundEmbryonic stem cells and retinal repair
Vugler, A., Lawrence, J. M., Walsh, J., Carr, A. F., Gias, C., Semo, M., Ahmado, A., da Cruz, L., Andrews, P. W., & Coffey, P. J. (2007) · Mechanisms of Development · doi:10.1016/j.mod.2007.08.002 · Cited by 80
“Use of enzymes to digest these matrix components has resulted in enhanced neuronal regrowth and restoration of function (Bradbury et al., 2002; Moon et al., 2002).”
Siegel, C. S., Fink, K. L., Strittmatter, S. M., & Cafferty, W. B. J. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3713-14.2015 · Cited by 77
“, 2014) or pharmacologically (Schnell and Schwab, 1990; Bradbury et al., 2002; GrandPre et al., 2002; Li et al., 2004; Wang et al., 2006, 2011) has shown some increase in axon regeneration;”
BackgroundMolecular and Cellular Mechanisms of Axonal Regeneration After Spinal Cord Injury
van Niekerk, E. A., Tuszynski, M. H., Lu, P., & Dulin, J. N. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r115.053751 · Cited by 81
Kataria, H., Alizadeh, A., Shahriary, G. M., Rizi, S. S., Henrie, R., Santhosh, K. T., Thliveris, J. A., & Karimi‐Abdolrezaee, S. (2017) · Glia · doi:10.1002/glia.23264 · Cited by 80
“However, Nrg-1 treatment had no effects on the expression of CSPG core protein suggesting that its effects are primarily targeted at GAGs component of CSPGs which are the main inhibitory components of CSPGs (Bradbury et al., 2002; Crespo, Asher, Lin, Rhodes, & Fawcett, 2007; McKeon, Hoke, & Silver, 1995).”
BackgroundMelrose, J. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14652 · Cited by 75
Extracellular matrix and matrix metalloproteinases in sciatic nerve
Platt, C. I., Krekoski, C. A., Ward, R. V., Edwards, D. R., & Gavrilović, J. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10783 · Cited by 72
“In contrast, one reason for the lack of CNS neuronal regeneration seems to be a lack of such turnover, because exposure of nerves to a proteoglycan-degrading enzyme (albeit of bacterial origin) results in enhanced functional regeneration (Bradbury et al., 2002).”
BackgroundFord, E., Pearlman, J., Ruan, T., Manion, J., Waller, M. A., Neely, G. G., & Caron, L. (2020) · Cells · doi:10.3390/cells9112517 · Cited by 74
Optic nerve regeneration screen identifies multiple genes restricting adult neural repair
Lindborg, J. A., Tran, N. M., Chenette, D. M., DeLuca, K., Foli, Y., Kannan, R., Sekine, Y., Wang, X., Wollan, M., Kim, I.-J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108777 · Cited by 72
“Chondroitinase ABC augments axon sprouting and functional recovery after spinal cord injury (Bradbury et al., 2002; Cafferty et al., 2007; Massey et al., 2006).”
BackgroundAdult rat forelimb dysfunction after dorsal cervical spinal cord injury
Onifer, S. M., Zhang, Y. P., Burke, D. A., Brooks, D. L., Decker, J. A., McClure, N. J., Floyd, A. R., Hall, J., Proffitt, B. L., Shields, C. B., et al. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.10.016 · Cited by 71
Lemarchant, S., Pruvost, M., Hébert, M., Gauberti, M., Hommet, Y., Briens, A., Maubert, E., Gueye, Y., Feron, F. P., Petite, D., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.02.005 · Cited by 74
“anti-Nogo-A) are considered in strategies to promote neuroregeneration (Bradbury and Carter, 2011; Bradbury et al., 2002; Kwon et al., 2011; Tomet al., 2009; Zuo et al., 1998, 2002).”
Asher, R. A., Morgenstern, D. A., Properzi, F., Nishiyama, A., Levine, J. M., & Fawcett, J. W. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.02.001 · Cited by 70
Self-citationWu, J., Huang, W., Tsai, Y., Chen, Y., & Cheng, H. (2008) · Journal of Neurosurgery Spine · doi:10.3171/spi/2008/8/3/208 · Cited by 71
Matrix metalloproteinases and proteoglycans in axonal regeneration
Pizzi, M. A., & Crowe, M. J. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.12.012 · Cited by 76
Gulati, K., & Poluri, K. M. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-015-9642-2 · Cited by 58
Perineuronal nets control visual input via thalamic recruitment of cortical PV interneurons
Faini, G., Aguirre, A., Landi, S., Lamers, D., Pizzorusso, T., Ratto, G. M., Deleuze, C., & Bacci, A. (2018) · eLife · doi:10.7554/elife.41520 · Cited by 69
“Importantly, PV cells are known to strongly modulate the gain of contrast sensitivity (Atallah et al., 2012), and improve network synchrony during g-oscillations (Cardin et al., 2009; Sohal et al., 2009; Isaacson and Scanziani, 2011; Buzsáki and Wang, 2012).”
BackgroundInfluentialHarris, N. G., Mironova, Y. A., Hovda, D. A., & Sutton, R. L. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181cb5bee · Cited by 70
“This has been shown to be beneficial after spinal cord injury by enhanced sprouting, commensurate with an electrophysiological and behavioral improvement (84, 85).”
Sustained dual drug delivery of anti-inhibitory molecules for treatment of spinal cord injury
Wilems, T. S., & Sakiyama‐Elbert, S. E. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.031 · Cited by 74
“Removal of inhibition via enzymatic cleavage of the glycosaminoglycan chains from the core protein with bacterially-expressed ChABC has consistently shown robust increases in neuronal outgrowth, although the core protein has some remaining inhibitory effect [16].”
BackgroundMultiple Channel Bridges for Spinal Cord Injury: Cellular Characterization of Host Response
Yang, Y., Laporte, L. D., Zelivyanskaya, M. L., Whittlesey, K. J., Anderson, A. J., Cummings, B. J., & Shea, L. D. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2009.0081 · Cited by 73
“Strategies to degrade the scar, such as the delivery of chondroitinase ABC, an enzyme that degrades CSPG, may be necessary.(26,27) Macrophages, Schwann cells, fibroblasts, and endothelial cells are expected to be located at or near biomaterials implanted into the injured spinal cord; however, their relative distributi…”
Andrews, M. R., & Stelzner, D. J. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2007.0353 · Cited by 70
“…of axons were examined immunohistochemically, in addition to GAP-43 expression (a general label for growing or sprouting axons; Chong et al., 1994, Bradbury et al., 2002) to determine potential differences between OECs and SCs. Axonal analysis was performed within the lesion cavity in the groups…”
Howell, M. D., & Gottschall, P. E. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.05.034 · Cited by 68
“Intrathecal injection of Ch’ase after spinal cord injury promoted regeneration of ascending and descending sensory neurons, increased post-synaptic activity, and restored motor function (Bradbury et al., 2002), a finding confirmed in other studies (Barritt et al.”
ResultZhang, H., Muramatsu, T., Murase, A., Yuasa, S., Uchimura, K., & Kadomatsu, K. (2006) · Glycobiology · doi:10.1093/glycob/cwj115 · Cited by 70
“Another marker for regenerating axons, anti-growth-associated protein-43 (GAP-43) (King et al., 2001; Bradbury et al., 2002), also demonstrated enhanced axonal regeneration in GlcNAc6ST-1–/– mice (Figure 6C).”
InfluentialAbou‐Abbass, H., Abou‐El‐Hassan, H., Bahmad, H. F., Zibara, K., Zebian, A., Youssef, R., Ismail, J. N., Zhu, R., Zhou, S., Dong, X., et al. (2016) · Electrophoresis · doi:10.1002/elps.201500585 · Cited by 79
Lentiviral Delivery of miR-133b Improves Functional Recovery After Spinal Cord Injury in Mice
Theis, T., Yoo, M., Park, C. S., Chen, J., Kügler, S., Gibbs, K. M., & Schachner, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0007-z · Cited by 73
Coulson‐Thomas, V. J., Lauer, M. E., Soleman, S., Zhao, C., Hascall, V. C., Day, A. J., & Fawcett, J. W. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.710673 · Cited by 75
“Moreover, these HA-binding CS proteoglycans become more abundant during the weeks after injury (107) and can bind a number of inhibitory molecules and contribute to the failure of axonal growth through the scar tissue (6, 15, 108 –112).”
BackgroundSelf-citationJain, A., Brady‐Kalnay, S. M., & Bellamkonda, R. V. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20161 · Cited by 69
“This strategy helps to partially alleviate the CSPG-mediated inhibition in vitro and in vivo (McKeon et al., 1995; Zuo et al., 1998; Bradbury et al., 2002).”
BackgroundMorgenstern, D. A., Asher, R. A., Naidu, M. K., Carlstedt, T. P., Levine, J. M., & Fawcett, J. W. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00245-8 · Cited by 70
Self-citationTreatment of Neurodevelopmental Disorders in Adulthood
Castrén, E., Elgersma, Y., Maffei, L., & Hagerman, R. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3287-12.2012 · Cited by 63
“Local injections of ChABC promote functional recovery after a spinal cord lesion (Bradbury et al., 2002), and very recent data suggest that a similar kind of plastic state can be achieved with fluoxetine (Scali et al.”
BackgroundBretheau, F., Castellanos-Molina, A., Bélanger, D., Kusik, M., Mailhot, B., Boisvert, A., Vallières, N., Lessard, M., Gunzer, M., Liu, X., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33463-x · Cited by 74
An In Vitro Model of Reactive Astrogliosis and Its Effect on Neuronal Growth
Yu, P., Wang, H., Katagiri, Y., & Geller, H. M. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-452-0_21 · Cited by 62
“0 with 10 M KOH (will not go into solution until pH approaches 7), store in aliquots at −20°C; (2) 5 mL 37% PFA (1.”
BackgroundImatinib Enhances Functional Outcome after Spinal Cord Injury
Abrams, M. B., Nilsson, I., Lewandowski, S. A., Kjell, J., Codeluppi, S., Olson, L., & Eriksson, U. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038760 · Cited by 73
“Imatinib also counteracted other indices of tissue pathology, such as astrogliosis and CSPG deposition, which is presumably valuable because both the astroglial scar and CSPGs are considered detrimental to axon regeneration and functional outcome [24], [25], [26].”
BackgroundBeebe, N. L., Young, J. W., Mellott, J. G., & Schofield, B. R. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.0217-16.2016 · Cited by 71
“removal of PNs restores juvenile-like plasticity in adults and may represent a target for therapeutic intervention after CNS injury (Bradbury et al., 2002; Pizzorusso et al., 2002; Gogolla et al., 2009).”
BackgroundComplement Protein C3 Suppresses Axon Growth and Promotes Neuron Loss
Peterson, S. L., Nguyen, H. X., Mendez, O. A., & Anderson, A. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-11410-x · Cited by 69
Turi, G. (2003) · Florence Research (University of Florence) · Cited by 69
Training and anti-CSPG combination therapy for spinal cord injury
García‐Alías, G., & Fawcett, J. W. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.009 · Cited by 76
Self-citationMachine‐Assisted Discovery of Chondroitinase ABC Complexes toward Sustained Neural Regeneration
Kosuri, S., Borca, C. H., Mugnier, H., Tamasi, M., Patel, R. A., Perez, I., Kumar, S., Finkel, Z., Schloss, R. S., Cai, L., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102101 · Cited by 71
Current Concepts of Biomaterial Scaffolds and Regenerative Therapy for Spinal Cord Injury
Suzuki, H., Imajo, Y., Funaba, M., Ikeda, H., Nishida, N., & Sakai, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032528 · Cited by 69
“the injury and are trapped in the dense meshwork of scar tissue [15,17].”
BackgroundMuir, E. M., Fyfe, I., Gardiner, S., Li, L., Warren, P. M., Fawcett, J. W., Keynes, R. J., & ROGERS, J. H. (2009) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2009.11.002 · Cited by 68
Self-citation
Metadata
- Authors
- Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., & McMahon, S. B.
- Affiliations
- King's College London (GB)
- University of Cambridge (GB)
- University of London (GB)
- Corresponding author
- Bradbury, Elizabeth J.
- ORCID
- Venue
- Nature
- Published
- 2002-04
- Volume
- 416
- Issue
- 6881
- Pages
- 636-640
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2012928251
- Cited by
- 2,357
- References
- 31
- Citations by year
- 2026: 63 · 2025: 75 · 2024: 54 · 2023: 73 · 2022: 98 · 2021: 95 · 2020: 116 · 2019: 91 · 2018: 109 · 2017: 96 · 2016: 104 · 2015: 111 · 2014: 131 · 2013: 108 · 2012: 137
- FWCI
- 63.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Keywords
- chondroitinase ABC, spinal cord injury, chondroitin sulfate proteoglycans, glycosaminoglycan degradation, axon regeneration, glial scar, corticospinal tract, sensory axon regeneration, locomotor recovery, proprioception, central nervous system injury
- MeSH terms
- Animals, Axons, Electrophysiology, Ganglia, Spinal, Humans, Isoenzymes, Male, Motor Activity, Nerve Crush, Nerve Regeneration, Neurons, Protein Kinase C, Psychomotor Performance, Spinal Cord Injuries, Up-Regulation, Rats, Wistar, Chondroitin ABC Lyase, GAP-43 Protein, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.